Starlink failures highlight space sustainability concerns

When investing, your capital is at risk. — The femtech market is set to reach $60 billion USD by 2027. Why? Because it provides crucial innovations to improve the health and happiness of 50% of the global population – the women that menstruate, and those that don’t want to. Those that go through pregnancy and those who want to prevent it. Those who are tackling menopause, or teenage hormonal fluctuations, or new motherhood and want to understand and respond to the totally natural changes their bodies are undergoing. The list goes on. While femtech used to refer to the uterus and little more, its definition has expanded to infant nutrition, egg freezing, childcare support, menstrual tracking, data-driven health products and more. Unsurprisingly, the majority of the business leading the space are founded by women – women who noticed gaps in the market and recognised the expansive healthcare and lifestyle needs of billions of women worldwide that have traditionally been left behind by advancements in medicine and technology. And yet, only 10% of global investment goes into female-founded businesses – despite the fact that female-led businesses are more likely to exit than their male-founded counterparts. This is something that all of us in the investment space are looking to change – and it starts by recognising the ambitious, game-changing startups dedicated to improving the lives of women, at every phase of their lives, around the world. &SISTERS is one of these. Founded by daughter mother duo, Lucy and Claire, &SISTERS is developing the menstrual health ecosystem of the future. They recognised that a person menstruating uses 11,000 period products in their lifetime on average – and most are completely unaware that the products they reach for in the period care aisle are laden with chemicals and plastic. So, they set out…